|
Volumn 191, Issue 10, 2009, Pages 574-
|
Timing of bronchiolitis hospitalisations and respiratory syncytial virus immunoprophylaxis in non-metropolitan Western Australia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PALIVIZUMAB;
ANTIVIRUS AGENT;
MONOCLONAL ANTIBODY;
AUSTRALIA;
BRONCHIOLITIS;
COST EFFECTIVENESS ANALYSIS;
HIGH RISK PATIENT;
HOSPITALIZATION;
HUMAN;
IMMUNOPROPHYLAXIS;
INFECTION RISK;
LETTER;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
SEASONAL VARIATION;
DRUG ADMINISTRATION;
INFANT;
PRESCHOOL CHILD;
RESPIRATORY SYNCYTIAL VIRUS INFECTION;
TIME;
VIRAL BRONCHIOLITIS;
ANTIBODIES, MONOCLONAL;
ANTIVIRAL AGENTS;
BRONCHIOLITIS, VIRAL;
CHILD, PRESCHOOL;
DRUG ADMINISTRATION SCHEDULE;
HOSPITALIZATION;
HUMANS;
INFANT;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
RESPIRATORY SYNCYTIAL VIRUS, HUMAN;
TIME FACTORS;
WESTERN AUSTRALIA;
|
EID: 77449119467
PISSN: 0025729X
EISSN: 13265377
Source Type: Journal
DOI: 10.5694/j.1326-5377.2009.tb03319.x Document Type: Letter |
Times cited : (5)
|
References (5)
|